Concepedia

Arturo Villanueva

AV

Statistics

Publications

6

Citations

821

H-Index

6

Active since

2008

Affiliations

University of California, Los Angeles(Current)

Pfizer (United States)

UCLA Health

The University of Texas MD Anderson Cancer Center

Arturo Villanueva is an author at University of California, Los Angeles specializing in immunotherapy, cancer immunology, and oncology.

Publications per year

2008–2015

6

Publications

6

Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

Thinle Chodon, Begoña Comı́n-Anduix, Bartosz Chmielowski et al. · Clinical Cancer Research · 2014 · 253 citations · Full text

, , +17

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

Antoni Ribas, Begoña Comı́n-Anduix, Bartosz Chmielowski et al. · Clinical Cancer Research · 2009 · 212 citations · Full text

, , +17

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Rong Huang, Jason Jalil, James S. Economou et al. · Clinical Cancer Research · 2011 · 151 citations · Full text

, , +17

Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab

Zeynep Eroglu, Dae Won Kim, Xiaoyan Wang et al. · European Journal of Cancer · 2015 · 83 citations · Full text

, , +14

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma

Begoña Comı́n-Anduix, Yohan Lee, Jason Jalil et al. · Journal of Translational Medicine · 2008 · 81 citations · Full text

, , +17

1–5 of 6